First Light Diagnostics

07/20/2021

First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath® Analyzer

https://www.firstlightdx.com/2021/07/20/first-light-diagnostics-receives-fda-clearance-rapid-clostridiodes-difficile-test-multipath-analyzer/

05/05/2021

https://www.firstlightdx.com/2021/05/05/first-light-diagnostics-appoints-joanne-spadoro-as-chief-executive-officer/

Chelmsford, MA (May 5, 2021) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic resistant infections, has named Joanne Spadoro, PhD as President and Chief Executive Officer (CEO).

10/27/2020

https://www.firstlightdx.com/2020/10/27/first-light-diagnostics-receives-additional-funding-from-the-biomedical-advanced-research-and-development-authority-barda/

First Light Diagnostics Receives Additional Funding from the Biomedical Advanced Research and Development Authority (BARDA) October 27, 2020First Light Diagnostics

06/17/2020

Using primary patient samples directly without a culture step, First Light’s MultiPath™ technology delivers breakthrough acceleration in rapid AST results, enabling clinicians to get the patient on the optimal targeted, narrow-spectrum therapy at the onset of their multi-drug resistant infection. With pathogen identification in 30 minutes and AST results four hours later, the MultiPath platform is an easy to use, automated benchtop analyzer, with high throughput and continuous random access. Using the MultiPath platform, clinicians will be able to administer the most effective targeted therapy during the onset of multi-drug resistant infections versus waiting several days for results.

05/28/2020

First Light Diagnostics Names New Chief Financial Officer
https://www.firstlightdx.com/2020/05/28/first-light-diagnostics-names-new-chief-financial-officer/

05/21/2020

First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book

First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book May 21, 2020First Light Diagnostics

05/19/2020

First Light Diagnostics Receives $1.1 Million ‘Paycheck Protection Program’ Loan Under the CARES Act

First Light Diagnostics Receives $1.1 Million ‘Paycheck Protection Program’ Loan Under the CARES Act May 19, 2020First Light Diagnostics

05/06/2020

https://www.firstlightdx.com/2020/05/06/first-light-diagnostics-appoints-new-chief-operating-officer/

First Light Diagnostics Appoints New Chief Operating Officer

12/18/2019

https://www.firstlightdx.com/2019/12/18/first-light-diagnostics-receives-additional-funding-barda/

First Light Diagnostics Receives Additional Funding from the Biomedical Advanced Research and Development Authority (BARDA) December 18, 2019First Light Diagnostics

11/13/2019

https://www.firstlightdx.com/2019/11/13/dr-melvin-weinstein-member-first-light-diagnostics-clinical-advisory-board/

Dr. Melvin Weinstein Becomes a Member of First Light Diagnostics Clinical Advisory Board November 13, 2019First Light Diagnostics

10/30/2019

https://www.firstlightdx.com/2019/10/30/first-light-joins-global-initiative-to-combat-antibiotic-resistance/

Chelmsford, MA (October 30, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced their participation in the U.S. Centers for Disease Control and Preve...

10/16/2019

https://www.firstlightdx.com/2019/10/16/david-macdonald-to-present-at-bio-investor-forum/

Chelmsford, MA (October 16, 2019) – First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced that First Light’s President & CEO, David Macdonald will be among t...